B
BioStem Technologies
Biotech & Life Sciences · Pompano Beach, United States · Founded 2006 · IPO 2008
BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies MoreLess
BioStem Technologies is a regenerative medicine company that develops, manufactures, and commercializes placental-derived allografts for advanced wound care applications.
The company's business model is centered around the development and commercialization of regenerative therapies derived from perinatal tissues. BioStem Technologies operates in the advanced wound care market, a sector of the broader healthcare industry. Its product portfolio includes brands such as RHEO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC, which are designed to provide solutions for complex wounds.
The company serves a range of clients within the healthcare system, including hospitals, clinics, and other healthcare facilities that require advanced wound care treatments. As a publicly traded entity on the OTC markets (BSEM), BioStem Technologies is also focused on creating value for its shareholders through the advancement of its product pipeline and commercial activities.
Keywords: regenerative medicine, placental allografts, advanced wound care, perinatal tissue, life sciences, biotechnology, medical devices, healthcare products, pharmaceutical, biologics
Talent graph
BioStem Technologies's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where BioStem Technologies has talent and traffic
team presence
across markets
Patent intelligence
BioStem Technologies’s patent portfolio
16 active families in the valuation dataset.
Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.
Market sentiment
What the market is saying about BioStem Technologies
An AI-synthesized read of the highest-engagement posts about BioStem Technologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioStem Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.